Amrize price target lowered to $42 from $57 at UBS
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
UBS lowers target to $42 from $57; price $39.19; priceChangeSinceSignal -1.34.
Target: $42
Posted price: $39.19
Analyst firm: UBS
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.